Soini Y, Chia S C, Bennett W P, Groopman J D, Wang J S, DeBenedetti V M, Cawley H, Welsh J A, Hansen C, Bergasa N V, Jones E A, DiBisceglie A M, Trivers G E, Sandoval C A, Calderon I E, Munoz Espinosa L E, Harris C C
Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, MD 20892-4255, USA.
Carcinogenesis. 1996 May;17(5):1007-12. doi: 10.1093/carcin/17.5.1007.
The p53 tumor suppressor gene is commonly mutated in human hepatocellular carcinoma (HCC). The most frequent mutation in HCC in populations exposed to a high dietary intake of aflatoxin B1 (AFB1) is an AGGarg-->AGTser missense mutation in codon 249 of the p53 gene. We analyzed HCCs from Monterrey, Mexico, for the codon 249ser hotspot mutation. We also analyzed the serum AFB1-albumin adduct levels of the donors and family members to measure the current AFB1 exposure in this population. Moreover, the presence of hepatitis B and/or C viral infection (HBV or HCV) was analyzed serologically in the patients. Tumor cells were microdissected from tissue sections and exon 7 p53 sequences were amplified by polymerase chain reaction from genomic DNA and sequenced directly. The serological tests for anti-p53 antibodies, HBV or HCV were done by ELISA. Immunohistochemical analysis of p53 protein was done using a polyclonal rabbit antiserum (CM-1). Eight of 21 cases were positive by p53 immunohistochemistry. Of the 16 cases sequenced for exon 7 of p53 three codon 249 AGGarg-->AGTser mutations were found. Serum antibodies recognizing p53 protein were found in one of 18 patients. Positive serology for HBV and/or HCV was found in 12 of 20 cases. The serum AFB1-albumin adduct levels in this population ranged from 0.54 to 4.64 pmol aflatoxin/mg albumin. These results indicate that dietary AFB1 and hepatitis viruses are etiological agents in the molecular pathogenesis of HCC in this geographic region of Mexico.
p53肿瘤抑制基因在人类肝细胞癌(HCC)中常发生突变。在黄曲霉毒素B1(AFB1)膳食摄入量高的人群中,HCC最常见的突变是p53基因第249密码子处的AGGarg→AGTser错义突变。我们分析了来自墨西哥蒙特雷的HCC,检测第249密码子ser热点突变。我们还分析了捐赠者及其家庭成员的血清AFB1-白蛋白加合物水平,以衡量该人群当前的AFB1暴露情况。此外,对患者进行血清学分析,检测是否存在乙型和/或丙型肝炎病毒感染(HBV或HCV)。从组织切片中显微切割肿瘤细胞,通过聚合酶链反应从基因组DNA扩增p53基因第7外显子序列并直接测序。通过ELISA进行抗p53抗体、HBV或HCV的血清学检测。使用多克隆兔抗血清(CM-1)对p53蛋白进行免疫组织化学分析。21例中有8例p53免疫组织化学呈阳性。在对p53第7外显子测序的16例中,发现3例第249密码子AGGarg→AGTser突变。18例患者中有1例检测到识别p53蛋白的血清抗体。20例中有12例HBV和/或HCV血清学检测呈阳性。该人群的血清AFB1-白蛋白加合物水平在0.54至4.64 pmol黄曲霉毒素/毫克白蛋白之间。这些结果表明,膳食AFB1和肝炎病毒是墨西哥这个地理区域HCC分子发病机制中的致病因素。